• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Delcath closes 5 million share offering at $23.5 million | Funding Roundup

Delcath closes 5 million share offering at $23.5 million | Funding Roundup

July 21, 2011 By MassDevice staff

Delcath Chemosat

Delcath Systems Inc. (NSDQ:DCTH) closed its offering of 5 million shares of common stock with a reported $23.5 million raised.

Shares sold for $5.05, driving down the company’s shares 14 percent on The Street, from a closing price of $5.87 on July 14, the day of the offering, to $5.06 by the end of the day July 15.

The New York-based company granted the sole bookrunner in the deal, Jeffries & Company, an over-allotment option to purchase up to 750,000 shares more at the same price until mid-month August 2011, according to the report.

Delcath stock has had a number of spikes and troughs over the last year, and last month company president & CEO Eamonn Hobbs told MassDevice what might be driving the roller coaster:

Delcath is an extremely volatile stock and there a number of components to that. One is that it’s a stock that’s shareholder based, that’s dominated by retail shareholders who tend to be much more active traders. The trading volume is high and the volatility seems to be equally high. The stock seems to go up significantly on good news and down significantly on bad news — or no news.

Delcath shares closed at $5.09 today, 1 cent lower than yesterday.

Check out our interview with Delcath president & CEO Eamonn Hobbs from June, 2011.

Funding

Here’s a roundup of other dealflow and investment news:

  • Corgenix lands $1.5 million revolving credit facility
    Diagnostic test maker Corgenix Medical Corp. (OTC:CONX) announced that it closed on a $1.5 million secured revolving line of credit with LSQ Funding Group and is discussing moving its primary banking to U.S. Bank.

    "Our new credit facility, combined with the company’s prospects for a record year in fiscal 2012, will definitely help provide us the platform to access an additional $1.5 million in potential capital to pursue our planned expansion efforts and capitalize on other opportunities that may come our way," senior VP of operations and finance and CFO William Critchfield said in the report.
    Read more

  • VasoStar wins $1 million grant from Ohio Third Frontier
    VasoStar Inc. won a $1 million research grant from Ohio Third Frontier to commercialize an electromagnetic guidewire system for penetrating through chronic total occlusions in arteries as an alternative for open heart surgery.

    The Cleveland, Ohio-based company, a subsidiary of Frantz Medical Group, plans to use the funds to complete development and collect additional safety data in preparation for FDA and CE Mark bids.
    Read more

Filed Under: Business/Financial News, Funding Roundup, News Well Tagged With: Corgenix Medical Corp., Delcath Systems Inc., Frantz Medical Group, VasoStar Inc., Venture Capital/Private Equity

More recent news

  • Real-world data backs Route 92 reperfusion system
  • LivsMed unveils new surgical robot with telesurgery capabilities
  • JenaValve enrolls first patient in TAVR for AR study
  • HistoSonics expands insurance coverage for histotripsy treatment
  • Johnson & Johnson MedTech gets updated FDA nod for Varipulse PFA

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy